BrainStorm to start adult stem cell trial for ALS
(Reuters)
Biotechnology News
Reuters - BrainStorm Cell Therapeutics Inc received approval from Israel's Health Ministry for a clinical trial of its adult stem cell therapy for people with amyotrophic lateral sclerosis (ALS).
Source: Yahoo! News: Biotechnology News
Obama Admin Approves More Embryonic Stem Cell Research Funding
NIH Director Francis Collins has added two more lines of human embryonic stem cells to its Registry, bringing the current total to 93 lines approved for federal funding.
Approval for listing in the NIH registry allows federal taxpayer funds to be used for experiments with these cells, creating an incentive for investigators to destroy more embryos and bring their own embryonic stem cell lines to the federal feeding trough.
The two hESC lines are from BioTime, Inc., which designates them ESI-014 and ESI-017. According to the listing, the embryonic stem cells cannot be used for diagnostic or therapeutic uses.
Collins and the NIH have continued to tout embryonic stem cells, which have not helped a single patient, including pouring an increasing share of federal stem cell funds on human embryonic stem cells, decidedly NOT putting the patients first. Meanwhile they continue ignoring the published benefits of adult stem cells to thousands of patients. You can meet a few of those thousands whose health has been improved with adult stem cells. Ref. Source 5
Cloning Milestones Since Dolly the Sheep
(ContributorNetwork)
Biotechnology News
ContributorNetwork - Dolly the Sheep was born July 5, 1996, at the Roslin Institute in Edinburgh, Scotland. Her birth was normal and she even had lambs of her own. But Dolly was created in a test tube as a clone.
Source: Yahoo! News: Biotechnology News
Komen Sends Millions to Embryonic Stem Cell Research Centers
The Susan G. Komen for the Cure Foundation has long upset pro-life advocates for denying the abortion-breast cancer link and sending millions to the Planned Parenthood abortion business. New information shows Komen also supporting centers engaging in embryonic stem cell research.
As LifeNews.com reported last year, Komen spokesman John Hammarley confirmed 20 of Komen's 122 affiliates have made donations to Planned Parenthood and, in 2009, those contributions totaled $731,303. The Komen spokesman also confirmed Komen affiliates contributed about $3.3 million to the abortion business from 2004-2009.
Now, Karen Malec of the Coalition on Abortion/Breast Cancer has spent time examining Komen's 990 Forms for the IRS for 2010 and she found that Komen has active relationships with at least five research groups or educational facilities that engage in embryonic stem cell research, which requires the destruction of unborn children in their earliest days for stem cells that have yet to help any patients.
Komen is careful in its documents to state that none of the funds directly support embryonic stem cell research, saying in its Group Return for 2010 under a section entitled "Grant Statement" that "While Komen affiliates do not fund research grants directly, a portion of the funds raised by every Komen affiliate (approximately 25%) go to support the research and training grants program at Komen's International Headquarters."
The return shows donations from Komen totaling $3.75 million to Johns Hopkins University School of Medicine, $4.5 million to the University of Kansas Medical Center, $1 million to the U.S. National Cancer Institute, $1 million to the Society for Women's Health Research, and $600,000 to Yale University. Ref. Source 9